An agenda for personalized medicine

Ng, Pauline C., Murray, Sarah S., Levy, Samuel, Venter, J. Craig·2009·Nature

Cited by (328)

Items 101–200 of 328

  1. Canadian health care professionals' knowledge, attitudes and perceptions of nutritional genomics
    Mark R. Weir, Karine Morin, Nola M. Ries, David G. A. Castle · 2010 · British Journal Of Nutrition
  2. Direct-To-Consumer Genome Testing: Opportunities for Pharmacogenomics Research?
    Barbara Prainsack, Howard Wolinsky · 2010 · Pharmacogenomics
  3. Evaluation of genetic tests for susceptibility to common complex diseases: why, when and how?
    Caroline Fiona Wright, Mark Kroese · 2009 · Human Genetics
  4. Using Lifetime Risk Estimates in Personal Genomic Profiles: Estimation of Uncertainty
    Quanhe Yang, W. Dana Flanders, Ramal Moonesinghe, John P. A. Ioannidis, Idris Guessous, Muin J. Khoury · 2009 · The American Journal of Human Genetics
  5. The ‘Persons‘ and ‘Genomics‘ of Personal Genomics
    Jenny Reardon · 2010 · Personalized Medicine
  6. CRISPR Mediated Biosensing Toward Understanding Cellular Biology and Point‐of‐Care Diagnosis
    Yifan Dai, Yanfang Wu, Guozhen Liu, J. Justin Gooding · 2020 · Angewandte Chemie
  7. Estimating and disclosing the risk of developing Alzheimer‘s disease: challenges, controversies and future directions
    Jeffrey Scott Roberts, Sarah M Tersegno · 2010 · Future Neurology
  8. Considerations for the Impact of Personal Genome Information: A Study of Genomic Profiling among Genetics and Genomics Professionals
    Julianne M. O’Daniel, Susanne B. Haga, Huntington F. Willard · 2010 · Journal of Genetic Counseling
  9. Regulatory controls for direct-to-consumer genetic tests: a case study on how the FDA exercised its authority
    Margaret Curnutte · 2017 · New Genetics and Society
  10. Impact of Web-Based Case Conferencing on Cancer Genetics Training Outcomes for Community-Based Clinicians
    Kathleen Reilly Blazer, Christina A. Christie, Gwen C. Uman, Jeffrey N. Weitzel · 2012 · Journal of Cancer Education
  11. An Epidemiologic-Based Survey of Public Attitudes Towards Predictive Genetic Testing in Russia
    Oksana A. Makeeva, Valentina V. Markova, Allen D. Roses, Valery Pavlovich Puzyrev · 2010 · Personalized Medicine
  12. Synthesis of HIV-1 capsid protein assembly inhibitor (CAP-1) and its analogues based on a biomass approach
    Leonid V. Romashov, Valentine P. Ananikov · 2016 · Organic & Biomolecular Chemistry
  13. Likelihood ratios for genome medicine
    Alexander A. Morgan, Rong Chen, Atul Janardhan Butte · 2010 · Genome Medicine
  14. Direct‐to‐Consumer Personal Genomic Testing: A Case Study and Practical Recommendations for “Genomic Counseling”
    Amy Curry Sturm, Kandamurugu Manickam · 2012 · Journal of Genetic Counseling
  15. Person-centred medicine and mental health
    Luis Salvador‐Carulla, J. E. Mezzich · 2012 · Epidemiology and Psychiatric Sciences
  16. Suppression Subtractive Hybridization Versus Next-Generation Sequencing in Plant Genetic Engineering: Challenges and Perspectives
    Mahbod Sahebi, Mohamed Musa Hanafi, Parisa Azizi, Abdul Aziz Hakim, Sadegh Ashkani, Rambod Abiri · 2015 · Molecular Biotechnology
  17. Population Differences in Genetic Risk for Age-Related Macular Degeneration and Implications for Genetic Testing
    Kylee L. Spencer · 2012 · Archives of Ophthalmology
  18. A Review of Pharmacogenetics of Adverse Drug Reactions in Elderly People
    Maurizio Cardelli, Francesca Marchegiani, Andrea Corsonello, Fabrizia Lattanzio, Mauro Provinciali · 2012 · Drug Safety
  19. KATP channel-dependent metaboproteome decoded: systems approaches to heart failure prediction, diagnosis, and therapy
    D. Kent Arrell, Jelena Zlatkovic Lindor, Satsuki Yamada, André Terzic · 2011 · Cardiovascular Research
  20. The genetics of common kidney disease: a pathway toward clinical relevance
    P. Drawz, J. Sedor · 2011 · Nature Reviews Nephrology
  21. Direct to consumer genetic testing: insights from an internet scan
    Leonhard Hennen, Arnold Sauter, Els Van Den Cruyce · 2010 · New Genetics and Society
  22. Ethical issues raised by common copy number variants and single nucleotide polymorphisms of certain and uncertain significance in general medical practice
    Arthur L. Beaudet · 2010 · Genome Medicine
  23. Commentary: Children and Predictive Genomic Testing: Disease Prevention, Research Protection, and Our Future
    Beth Anne Tarini, K. P. Tercyak, Benjamin S. Wilfond · 2011 · Journal of Pediatric Psychology
  24. Jumping on the Train of Personalized Medicine: A Primer for Non- Geneticist Clinicians: Part 3. Clinical Applications in the Personalized Medicine Area
    Aihua Li, David Meyre · 2014 · Current Psychiatry Reviews
  25. Utility of CRISPR/Cas mediated electrochemical biosensors
    Jiajie Ma, Xinwei Li, Chenyang Lou, Xinyue Lin, Zhenzhong Zhang, Di Chen, Sen Yang · 2023 · Analytical Methods
  26. Association of direct‐to‐consumer genome‐wide disease risk estimates and self‐reported disease
    Cinnamon S. Bloss, Eric J. Topol, Nicholas J. Schork · 2011 · Genetic Epidemiology
  27. L’invention de la médecine personnalisée
    Marc Billaud, Xavier Guchet · 2015 · médecine/sciences
  28. Effects of single nucleotide polymorphism ascertainment on population structure inferences
    Kotaro Dokan, Sayu Kawamura, Kosuke M. Teshima · 2021 · G3 Genes Genomes Genetics
  29. Health care providers and direct-to-consumer access and advertising of genetic testing in the United States
    Melanie F. Myers · 2011 · Genome Medicine
  30. Comparative study between Next Generation Sequencing Technique and identification of microarray for Species Identification within blended food products
    Jung Youn Park, Seung Yong Lee, Cheul Min An, Jung-Ha Kang, Jihoon Kim, Jin Choul Chai, Jiayu Chen, Jin Seok Kang, Jeong Jin Ahn, Young Seek Lee et al. · 2012 · BioChip Journal
  31. Interpreting the Implications of DNA Ancestry Tests
    Jennifer K. Wagner · 2010 · Perspectives in biology and medicine
  32. Pharmacogenetic screening for drug therapy: From single gene markers to decision making in the next generation sequencing era
    Mladen Vassilev Tzvetkov, Nicolas von Ahsen · 2012 · Pathology
  33. Predictors of adverse psychological experiences surrounding genome-wide profiling for disease risk
    K. M. Broady, Kelly E. Ormond, Eric J. Topol, Nicholas J. Schork, Cinnamon S. Bloss · 2017 · Journal of Community Genetics
  34. Toward Personalized Medicine in the Neuropsychiatric Field
    Erik H.F. Wong, Jayne C. Fox, Mandy Ng, Chi‐Ming Lee · 2011 · International review of neurobiology
  35. DTC genetic testing companies fail transparency prescriptions
    Norman P. Lewis, Debbie M. Treise, Stephen I‐Hong Hsu, William L. Allen, Hannah Kang · 2011 · New Genetics and Society
  36. Digital phenotyping and data inheritance
    Sara Green, Mette Nordahl Svendsen · 2021 · Big Data & Society
  37. Crowdsourced direct-to-consumer genomic analysis of a family quartet
    Manuel Corpas, Willy Valdivia-Granda, Nazareth Torres, Bastian Greshake Tzovaras, Alain Coletta, Alexej Knaus, Andrew Harrison, Mike Cariaso, Federico Morán, Fiona G. G. Nielsen et al. · 2015 · BMC Genomics
  38. Optical nanosensors for in vivo physiological chloride detection for monitoring cystic fibrosis treatment
    Wenjun Di, Heather Ann Clark · 2020 · Analytical Methods
  39. Teaching Residents Genomic Pathology
    Richard L. Haspel · 2013 · Advances in Anatomic Pathology
  40. Genetics of Osteoporosis: Perspectives for Personalized Medicine
    Wenfeng Li, Shu-Xun Hou, Bin Yu, Dan Jin, Claude Férec, Jian‐Min Chen · 2010 · Personalized Medicine
  41. Reading the runes of my genome: a personal exploration of retail genetics
    Martin Richards · 2010 · New Genetics and Society
  42. TRIG on TRACK: Educating Pathology Residents in Genomic Medicine
    Richard L. Haspel, James B. Atkinson, Frederic G. Barr, Karen Lynn Kaul, Debra G. B. Leonard, Julianne M. O’Daniel, Henry M. Rinder, Joan A. Scott, Mark E. Sobel, V. O. Speights et al. · 2012 · Personalized Medicine
  43. Mass spectrometry-based analysis of eccrine sweat supports predictive, preventive and personalised medicine in a cohort of breast cancer patients in Austria
    Michael J. Bolliger, Daniel Wasinger, Julia Brunmair, Gerhard Hagn, Michael Wolf, Karin Preindl, Birgit Reiter, Andrea Bileck, Christopher Gerner, Florian Fitzal et al. · 2025 · The EPMA Journal
  44. Chapter 14: Cancer Genome Analysis
    Miguél Vázquez, Victor de la Torre, Alfonso Valencia · 2012 · PLoS Computational Biology
  45. Towards Personalized Medicine: Exploring the Consequences of the Effect Model-Based Approach
    Jean‐Pierre Boissel, Riad Kahoul, Emmanuel Amsallem, François Gueyffier, Margaret C. Haugh, François‐Henri Boissel · 2011 · Personalized Medicine
  46. Implications of Internet Availability of Genomic Information for Public Health Practice
    Bradford William Hesse, N. Arora, M.J. Khoury · 2012 · Public Health Genomics
  47. Risk categorization for complex disorders according to genotype relative risk and precision in parameter estimates
    Graham H.M. Goddard, Cathryn M. Lewis · 2010 · Genetic Epidemiology
  48. The Business Value and Cost–effectiveness of Genomic Medicine
    James M. Crawford, Mara G. Aspinall · 2012 · Personalized Medicine
  49. Misuse (and Abuse?) of the Concept of Empowerment. The Case of Online Offer of Predictive Direct-to-Consumer Genetic Tests
    Loredana Covolo, Sara Rubinelli, Grazia Orizio, Umberto Gelatti · 2012 · Journal of Public Health Research
  50. β-Blocking and Racial Variation in the Severity of Retinopathy of Prematurity
    William V. Good · 2012 · Archives of Ophthalmology
  51. Direct-to-consumer genetic testing for health-related purposes in the European Union
    Easac, Volker ter Meulen, Stefania Boccia, Martina Cornelia Cornel, Marc Delpech, Anne De Paepe, Xavier Estivill, MATS G. HANSSON, Katia Karalis, Andres Metspalu et al. · 2012
  52. Identifying subtypes of patients with neovascular age-related macular degeneration by genotypic and cardiovascular risk characteristics
    Michael Feehan, John M. Hartman, Richard Durante, Margaux A. Morrison, Joan W. Miller, Ivana K. Kim, Margaret M. DeAngelis · 2011 · BMC Medical Genetics
  53. Genetic polymorphisms for estimating risk of atrial fibrillation: a literature‐based meta‐analysis
    J. G. Smith, Peter Almgren, Gunnar Engström, Bo Hedblad, Pyotr G. Platonov, Christopher Newton‐Cheh, Olle Melander · 2012 · Journal of Internal Medicine
  54. Uncertainties of Nutrigenomics and Their Ethical Meaning
    Michiel Korthals, Rixt Komduur · 2009 · Journal of Agricultural and Environmental Ethics
  55. Advances in Nutrigenomics and Applications in Public Health: A Recent Update
    Swati Vyas · 2022 · Current Research in Nutrition and Food Science Journal
  56. Discovery of critical host factor, IL‐28B, associated with response to hepatitis C virus treatment
    Masashi Mizokami · 2011 · Journal of Gastroenterology and Hepatology
  57. The FDA and 23andMe: Violating the First Amendment or Protecting the Rights of Consumers?
    Linnea M. Baudhuin · 2014 · Clinical Chemistry
  58. Systematic evaluation of personal genome services for Japanese individuals
    城戸 隆, Minae Kawashima, Seiji Nishino, Melanie Swan, Naoyuki Kamatani, Atul Janardhan Butte · 2013 · Journal of Human Genetics
  59. In‐Transit Electroextraction of Small‐Molecule Pharmaceuticals from Blood
    Pavisara Nanthasurasak, Hong Heng See, Min Zhang, Rosanne Marieke Guijt, Michael Charles Breadmore · 2019 · Angewandte Chemie International Edition
  60. Genetics and Genomics to the Clinic: A Long Road ahead
    David Ginsburg · 2011 · Cell
  61. Current landscape of direct‐to‐consumer genetic testing and its role in ophthalmology: a review
    Paul Gerard Sanfilippo, Lisa S. Kearns, Philip H. Wright, David Anthony Mackey, Alex William Hewitt · 2015 · Clinical and Experimental Ophthalmology
  62. Attitudes towards Social Networking and Sharing Behaviors among Consumers of Direct-to-Consumer Personal Genomics
    Sandra Soo‐Jin Lee, Simone Lucia Vernez, Kelly E. Ormond, Mark S. Granovetter · 2013 · Journal of Personalized Medicine
  63. Risk estimates for complex disorders: comparing personal genome testing and family history
    Lila Aiyar, Cheryl T. Shuman, Robin Z. Hayeems, Annie Dupuis, Shuye Pu, Shoshana J. Wodak, David A. Chitayat, Lea Velsher, Jill Davies · 2013 · Genetics in Medicine
  64. Advances in Human Biology: Combining Genetics and Molecular Biophysics to Pave the Way for Personalized Diagnostics and Medicine
    Emil G Alexov · 2014 · Advances in Biology
  65. ‘Just a Bit of Fun’: How Recreational is Direct-to-Customer Genetic Testing?
    Heike Felzmann · 2015 · The New Bioethics
  66. A randomized trial of the clinical utility of genetic testing for obesity: Design and implementation considerations
    Catharine Wang, Erynn S. Gordon, Catharine B. Stack, Ching‐Ti Liu, Tricia Norkunas Cunningham, Lisa Wawak, Michael F. Christman, Robert C. Green, Deborah J. Bowen · 2013 · Clinical Trials
  67. Development and Validation of a Taxonomy for Characterizing Measurements in Health Self-Quantification
    Manal Almalki, Kathleen Mary Gray, Fernando J. Martin-Sanchez · 2017 · Journal of Medical Internet Research
  68. Bayesian multilevel multivariate logistic regression for superiority decision-making under observable treatment heterogeneity
    Xynthia Kavelaars, Joris Mulder, Maurits Clemens Kaptein · 2023 · BMC Medical Research Methodology
  69. Customized optoelectronic in-ear sensor approaches for unobtrusive continuous monitoring of cardiorespiratory vital signs
    Vladimír Blažek, Boudewijn Venema, Steffen K. Leonhardt, Paul Blažek, cyLEDGE Media, Vienna, Austria · 2018 · International Journal of Industrial Engineering and Management
  70. Predictive Ability of Direct-to-Consumer Pharmacogenetic Testing: When is Lack of Evidence Really lack of Evidence?
    Rachel R. J. Kalf, Rachel Bakker, A. Cecile J.W. Janssens · 2013 · Pharmacogenomics
  71. Practical considerations to guide development of access controls and decision support for genetic information in electronic medical records
    Diana C. Darcy, Eleanor T. Lewis, Kelly E. Ormond, John David Clark, Jodie A. Trafton · 2011 · BMC Health Services Research
  72. Parkinson disease—moving beyond association
    Owen A. Ross, Matthew James Farrer · 2010 · Nature Reviews Neurology
  73. Direct‐to‐Consumer Genetic Testing: Introduction to the Special Issue
    Melanie F. Myers, Barbara A. Bernhardt · 2012 · Journal of Genetic Counseling
  74. Scientific reporting is suboptimal for aspects that characterize genetic risk prediction studies: a review of published articles based on the Genetic RIsk Prediction Studies statement
    Adriana I. Iglesias, Raluca Mihăescu, John P. A. Ioannidis, Muin J. Khoury, Julian Little, Cornelia M. van Duijn, A. Cecile J.W. Janssens · 2014 · Journal of Clinical Epidemiology
  75. Personalization in biomedical-informatics: Methodological considerations and recommendations
    Maurits Clemens Kaptein · 2019 · Journal of Biomedical Informatics
  76. Il Museo di Storia Naturale dell'Università degli Studi di Firenze. Le collezioni antropologiche ed etnologiche / The Museum of Natural History of the University of Florence. The Anthropological and Ethnological Collections
    Jacopo Moggi‐Cecchi, Roscoe Stanyon · 2014 · Cataloghi e collezioni
  77. A Review on Korean Medicine and Personalized Medicine: Syndrome-based Personalized Medicine on the Basis of Syndrome Differentiation and Treatment
    Jae Min Han, Woong Mo Yang · 2014 · 대한한의학회지
  78. Assessing the social impact of direct-to-consumer genetic testing: Understanding sociotechnical architectures
    Shobita Parthasarathy · 2010 · Genetics in Medicine
  79. Language matters: precision health as a cross-cutting care, research and policy agenda
    Philip Payne, Don E. Detmer · 2020 · Journal of the American Medical Informatics Association
  80. The future scalability of pH-based genome sequencers: A theoretical perspective
    Jonghyun Go, Muhammad A. Alam · 2013 · Journal of Applied Physics
  81. Psychiatric genetics in South Africa: cutting a rough diamond
    GEB Wright, Dana J.H. Niehaus, Liezl Koen, Britt I. Drögemöller, Louise Warnich · 2011 · African Journal of Psychiatry
  82. Personal genomic testing for nutrition and wellness in Australia: A content analysis of online information
    Erin Tutty, Chriselle L. Hickerton, Melissa M. Adamski, Sylvia A. Metcalfe · 2019 · Nutrition & Dietetics
  83. Genome-Wide Association Studies and Diet
    Lynnette Robyn Ferguson · 2010 · World review of nutrition and dietetics
  84. Incorporating prior expert knowledge in learning Bayesian networks from genetic epidemiological data
    Chengwei Su, Mark E. Borsuk, Angeline Andrew, Margaret Rita Karagas · 2014 · IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB)
  85. Genetic Testing Integration Panels (GTIPs): A Novel Approach for Considering Integration of Direct‐To‐Consumer and Other New Genetic Tests into Patient Care
    Wendy R. Uhlmann, Richard R. Sharp · 2012 · Journal of Genetic Counseling
  86. Comparison of Commercial Genetic-Testing Services in Korea with 23andMe Service
    Sollip Kim, Ki-Won Eom, Chong-Rae Cho, Tae Hyun Um · 2014 · BioMed Research International
  87. An Indian eye to personalized medicine
    Shaurya Jauhari, Syed A. Rizvi · 2014 · Computers in Biology and Medicine
  88. Handbook of Genomics and the Family
    Kenneth P. Tercyak · 2010 · Issues in clinical child psychology
  89. The Potential Application of Personalized Preventive Research
    Minkyo Song, H.-W. Lee, Daehee Kang · 2014 · Japanese Journal of Clinical Oncology
  90. Interpreting noncoding genetic variation in complex traits and human disease
    Ward, Lucas D, Kellis, Manolis · 2012 · Nature Biotechnology
  91. Characterizing and Interpreting Genetic Variation from Personal Genome Sequencing
    Anna Johansson, Lars Feuk · 2011 · Methods in molecular biology
  92. Improving Oncology Outcomes Through Targeted Therapeutics Will Require Electronic Delivery Systems
    Tibor van Rooij, Sharon Marsh · 2011 · Future Oncology
  93. Personalized Medicine: Ethics for Clinical Trials
    G. Terry Sharrer · 2011 · Methods in molecular biology
  94. The DEER database: A bridge connecting drugs, environmental effects, and regulations
    Qi Yu, Jing‐Fei Huang · 2013 · Gene
  95. Genome-wide Association: From Confounded to Confident
    Joseph Glessner, Hakon H. Hakonarson · 2011 · The Neuroscientist
  96. The Application of Genetics and Genomics to Cancer Prevention
    Kathleen Calzone, Daniel J Wattendorf, Barbara Karen Dunn · 2010 · Seminars in Oncology
  97. Editorial [Science Communication: Significance for Genome-Based Personalized Medicine – A View from the Asia-Pacific]
    Kazuto Kato, Kei Kano, Tetsuya Shirai · 2010 · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine
  98. Optimal personalized treatment learning models with insurance applications
    Leo Guelman · 2015 · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
  99. Enhancing systems medicine beyond genotype data by dynamic patient signatures: having information and using it too
    Frank Emmert‐Streib, Matthias Dehmer · 2013 · Frontiers in Genetics
  100. Tools to Identify Organ Rejection and Immune Quiescence for Biological Understanding and Personalized Medical Care
    Paul A. Keown, W. Robert McMaster, Bruce M. McManus · 2010 · Biomarkers in Medicine